undefined

undefined

Home page

Jiudian Welcomes Hunan Youth Science and Technology Talent Special Training Camp for Research Visit, R&D and Smart Manufacturing Capabilities Earn High Praise

Jiudian Welcomes Hunan Youth Science and Technology Talent Special Training Camp for Research Visit, R&D and Smart Manufacturing Capabilities Earn High Praise

On May 20, the seventh session of the "Xiangzhi Xingxiang" Hunan Youth Science and Technology Talent Special Training Camp visited Jiudian Pharmaceutical. A delegation of 30 young science and technology talent representatives from universities, research institutes, and leading technology enterprises across the province conducted an on-site survey of Jiudian Pharmaceutical's R&D innovation and smart manufacturing achievements. Director Shu from the Clinical Business Division's Hunan Region warmly received the visiting trainees.

21

2026

/

05

Technology Leadership, Quality First: Jiudian Hongyang Named Hunan Provincial Manufacturing Single-Champion Enterprise

Technology Leadership, Quality First: Jiudian Hongyang Named Hunan Provincial Manufacturing Single-Champion Enterprise

The Hunan Provincial Department of Industry and Information Technology officially announced the list of the sixth batch of Hunan Provincial Manufacturing Single-Champion Enterprises, with Jiudian Hongyang successfully making the cut thanks to its Hydrotalcite active pharmaceutical ingredient (API).

18

2026

/

05

Jiudian Hongyang Shines at the 94th API China, Showcasing Full-Chain Service Advantages at the Industry's Premier Event

Jiudian Hongyang Shines at the 94th API China, Showcasing Full-Chain Service Advantages at the Industry's Premier Event

Harnessing the momentum of industry advancement and embracing the journey toward pharmaceutical innovation, the much-anticipated 94th API China was held in Shanghai from May 13 to 15. Jiudian Hongyang Pharmaceutical made a powerful appearance at the event, presenting its core active pharmaceutical ingredients (APIs), high-end pharmaceutical excipients, and one-stop CMO services. With its full-chain service capabilities, the company stood out at this premier industry platform, attracting numerous domestic and international pharmaceutical enterprises for in-depth discussions and collaboration.

18

2026

/

05

Jiudian Pharma Shines at the 92nd National Pharmaceutical Fair, Embracing Win-Win Partnerships

Jiudian Pharma Shines at the 92nd National Pharmaceutical Fair, Embracing Win-Win Partnerships

From May 13 to 15, the 92nd National Pharmaceutical Fair (PHARMCHINA) was grandly held at the Shanghai National Exhibition and Convention Center. As one of the largest and most influential professional events in China's healthcare and wellness industry, this year's fair brought together nearly 3,000 enterprises from both domestic and international pharmaceutical and health nutrition sectors. Jiudian Pharma's General Manager, Mr. Yang, and Operations Director, Ms. Zhu, led the company's sales management team and key business personnel to the event, showcasing a number of flagship products.

15

2026

/

05

Dual-Drive Strategy of "Product & Brand" Propels Jiudian Pharmaceutical's Brand Value to New Heights

On May 10, the "2026 China Brand Value Evaluation Information Release" event, hosted by the China Council for Brand Promotion and Xinhua News Agency Brand Work Office, and organized by China Brand magazine, was held in Deqing, Zhejiang Province. Hunan Jiudian Pharmaceutical Co., Ltd. was ranked 20th on the Pharmaceutical and Health list, with a brand strength score of 870 and a brand value of RMB 2.949 billion, achieving a triple leap in brand strength, brand value, and industry ranking.

11

2026

/

05

Crisaborole Ointment Approved for Marketing; Jiudian Expands Indications for Topical Products

Crisaborole Ointment Approved for Marketing; Jiudian Expands Indications for Topical Products

Recently, Jiudian Pharmaceutical's Crisaborole Ointment officially received a registration approval from the National Medical Products Administration (NMPA), deemed to have passed the generic drug consistency evaluation. The product is a National Medical Insurance Category B drug, indicated for the topical treatment of mild-to-moderate atopic dermatitis in adults and children aged 3 months and older. The approval marks a new breakthrough for Jiudian Pharmaceutical in the topical drug sector, expanding the therapeutic indications of its topical product portfolio from anti-inflammatory and analgesic fields to the regulation of cutaneous immune-inflammatory responses.

08

2026

/

05

Jiudian Hongyang Successfully Passes On-Site Inspection for Brazil's ANVISA Certification, Marking a Major Step in Global Expansion

Jiudian Hongyang Successfully Passes On-Site Inspection for Brazil's ANVISA Certification, Marking a Major Step in Global Expansion

Recently, Jiudian Hongyang successfully completed the on-site cGMP inspection by the Brazilian National Health Surveillance Agency (ANVISA) for its secnidazole product line. The company's standardized, end-to-end production quality management system received high praise from the ANVISA inspectors. This marks the third time since its establishment that Jiudian Hongyang has undergone an on-site inspection by an international authoritative pharmaceutical regulatory agency. Brazil is the seventh-largest pharmaceutical market in the world. This certification not only represents a key opportunity for the company's products to enter the global market but also serves as an important test of its production quality management system against international standards, holding far-reaching significance for the company's international development.

07

2026

/

05

Deepening Presence in the Asian Market: Jointly Building the Future of Pharmaceuticals – Jiudian Hongyang Makes Its Debut at CPHI Japan

Deepening Presence in the Asian Market: Jointly Building the Future of Pharmaceuticals – Jiudian Hongyang Makes Its Debut at CPHI Japan

From April 21 to 23, the 23rd World Pharmaceutical Raw Materials Exhibition in Japan (CPHI Japan 2026) was grandly held at the Ariake International Convention and Exhibition Center in Tokyo. Ms.Zeng, Director of International Development at Jiudian Hongyang, led her team to showcase a range of specialized APIs and excipients as well as customized pharmaceutical solutions. At this premier industry event in the Asia-Pacific pharmaceutical APIs sector, the team accurately addressed the core demands of the Japanese and East Asian markets, securing several significant cooperation agreements.

28

2026

/

04

< 1 2 3 4...17 >

Hunan Jiudian

Bldg A1, Wukuang Lugu Science and Technology Industry Park, No.28 Lutian Road, Hi-tech development zone, Changsha, Hunan, China TEL. 0086-731-88220222

1

Business license

Powered by：CEglobal Privacy policy